NO833976L - Fremgangsmaate ved fremstilling av steroidforbindelser med snevert partikkelstoerrelseomraade - Google Patents
Fremgangsmaate ved fremstilling av steroidforbindelser med snevert partikkelstoerrelseomraadeInfo
- Publication number
- NO833976L NO833976L NO833976A NO833976A NO833976L NO 833976 L NO833976 L NO 833976L NO 833976 A NO833976 A NO 833976A NO 833976 A NO833976 A NO 833976A NO 833976 L NO833976 L NO 833976L
- Authority
- NO
- Norway
- Prior art keywords
- particle size
- hydrogen
- particles
- methyl
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8231278 | 1982-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO833976L true NO833976L (no) | 1984-05-03 |
Family
ID=10533991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO833976A NO833976L (no) | 1982-11-02 | 1983-11-01 | Fremgangsmaate ved fremstilling av steroidforbindelser med snevert partikkelstoerrelseomraade |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0108606B1 (Direct) |
| JP (1) | JPS5995300A (Direct) |
| AT (1) | ATE38236T1 (Direct) |
| DE (1) | DE3378318D1 (Direct) |
| DK (1) | DK499683A (Direct) |
| ES (1) | ES8504486A1 (Direct) |
| FI (1) | FI834025L (Direct) |
| GB (1) | GB2130588B (Direct) |
| GR (1) | GR79688B (Direct) |
| IE (1) | IE56205B1 (Direct) |
| NO (1) | NO833976L (Direct) |
| PT (1) | PT77593B (Direct) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8328929D0 (en) | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
| US6458811B1 (en) | 1996-03-26 | 2002-10-01 | Eli Lilly And Company | Benzothiophenes formulations containing same and methods |
| GB2345851B (en) * | 2000-01-18 | 2004-05-26 | Gavin Paul Vinson | A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour |
| GB2375958B (en) * | 2001-04-09 | 2005-03-02 | George Margetts | The use of steroids to lower the levels of cortisol |
| GB2400554B (en) * | 2003-04-16 | 2007-04-18 | George Margetts | Treatment of angiotensin II-induced cardiovascular disease |
| CN103169714A (zh) | 2005-07-12 | 2013-06-26 | Dmi生物科学公司 | 治疗疾病的方法和产品 |
| GB2627797A (en) * | 2023-03-02 | 2024-09-04 | Norbrook Lab Ltd | Trilostane formulation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3296255A (en) * | 1963-11-29 | 1967-01-03 | Sterling Drug Inc | 2-cyano steroids |
| GB1123770A (en) * | 1966-11-15 | 1968-08-14 | Sterling Drug Inc | 2-cyano-3-oxo-steroids |
| FR2408345A1 (fr) * | 1976-11-30 | 1979-06-08 | Besins Jean Louis | Nouvelle composition a action anti-conceptionnelle |
| US4062954A (en) * | 1976-12-27 | 1977-12-13 | Sterling Drug Inc. | Process for using a steroid compound |
| US4160027A (en) * | 1977-12-20 | 1979-07-03 | Sterling Drug Inc. | Steroid cyanoketones and intermediates |
| GB8328929D0 (en) | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
-
1983
- 1983-10-28 ES ES526874A patent/ES8504486A1/es not_active Expired
- 1983-10-28 JP JP58202482A patent/JPS5995300A/ja active Granted
- 1983-11-01 DK DK499683A patent/DK499683A/da not_active Application Discontinuation
- 1983-11-01 NO NO833976A patent/NO833976L/no unknown
- 1983-11-01 GB GB08329173A patent/GB2130588B/en not_active Expired
- 1983-11-02 IE IE2563/83A patent/IE56205B1/en not_active IP Right Cessation
- 1983-11-02 DE DE8383306665T patent/DE3378318D1/de not_active Expired
- 1983-11-02 GR GR72848A patent/GR79688B/el unknown
- 1983-11-02 PT PT77593A patent/PT77593B/pt not_active IP Right Cessation
- 1983-11-02 FI FI834025A patent/FI834025L/fi not_active Application Discontinuation
- 1983-11-02 AT AT83306665T patent/ATE38236T1/de not_active IP Right Cessation
- 1983-11-02 EP EP83306665A patent/EP0108606B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB2130588A (en) | 1984-06-06 |
| JPS5995300A (ja) | 1984-06-01 |
| EP0108606A1 (en) | 1984-05-16 |
| DK499683D0 (da) | 1983-11-01 |
| FI834025A7 (fi) | 1984-05-03 |
| PT77593A (en) | 1983-12-01 |
| IE832563L (en) | 1984-05-02 |
| DE3378318D1 (en) | 1988-12-01 |
| GB2130588B (en) | 1986-08-13 |
| FI834025L (fi) | 1984-05-03 |
| ES526874A0 (es) | 1985-05-01 |
| EP0108606B1 (en) | 1988-10-26 |
| PT77593B (en) | 1986-03-18 |
| DK499683A (da) | 1984-05-03 |
| FI834025A0 (fi) | 1983-11-02 |
| ATE38236T1 (de) | 1988-11-15 |
| GR79688B (Direct) | 1984-10-31 |
| IE56205B1 (en) | 1991-05-22 |
| GB8329173D0 (en) | 1983-12-07 |
| JPH0443078B2 (Direct) | 1992-07-15 |
| ES8504486A1 (es) | 1985-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4187423B2 (ja) | ジプラシドン組成物 | |
| Han et al. | Passivation of high-surface-energy sites of milled ibuprofen crystals via dry coating for reduced cohesion and improved flowability | |
| US11000522B2 (en) | Bromocriptine formulations | |
| NO324037B1 (no) | Pulver for anvendelse i en torrpulverinhalator og fremgangsmate for fremstilling av pulveret | |
| HUP0401935A2 (hu) | Mikronizált progeszterontartalmú gyógyszerészeti készítmény, eljárás előállítására és alkalmazásai | |
| EP1492500B1 (en) | Formoterol and ciclesonide aerosol formulations | |
| Yamamura et al. | Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride | |
| Chiou et al. | Micronization of meloxicam using a supercritical fluids process | |
| JP2013516394A (ja) | 医薬用途用の１−（１ｈ−１，２，４−トリアゾール−１−イル）ブタン−２−オール誘導体、および前記１−（１ｈ−１，２，４−トリアゾール−１−イル）ブタン−２−オール誘導体を調製するための、実質的に不定の結晶形状を有する１−（１ｈ−１，２，４−トリアゾール−１−イル）ブタン−２−オール誘導体の使用 | |
| Pazesh et al. | Comminution-amorphisation relationships during ball milling of lactose at different milling conditions | |
| NO833976L (no) | Fremgangsmaate ved fremstilling av steroidforbindelser med snevert partikkelstoerrelseomraade | |
| NO320894B1 (no) | Partikler av benzotiofener, farmasoytiske formuleringer som omfatter disse samt anvendelse av partiklene | |
| de Villiers et al. | The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing | |
| JP2576927B2 (ja) | 細粒核 | |
| CN112741819A (zh) | 一种盐酸氟西汀胶囊及其制备方法 | |
| Sharma et al. | Formulation, evaluation and optimization of mouth dissolving tablets of losartan potassium: effect of coprocessed superdisintegrants | |
| CN103655492A (zh) | 一种索法酮滴丸剂及其制备方法和应用 | |
| Orr et al. | Applications of particle size analysis in the pharmaceutical industry | |
| Jadhav et al. | Liquisolid technique a novel approach to enhance solubility and dissolution rate: a review | |
| Thwaites | The effect of mixing time and mixer intensity on the compression properties of tablettose® | |
| CN104382936B (zh) | 一种磺化去氢松香酸铋的口服固体制剂及其制备方法 | |
| CN120795051A (zh) | 一种黄体酮共晶物及其制备方法和应用 | |
| CN120795050A (zh) | 一种黄体酮共晶物及其制备方法和应用 | |
| Bramanti et al. | Pharmaceutical availability of digoxin tablets | |
| Shrikhande et al. | Rifampicin and Isoniazid microcapsules for treatment of tuberculosis |